Andrey has a laboratory-based background in protein interaction, systems biology and more recently worked within Kirby Institute's Viral Hepatitis Epidemiology and Prevention Program on HCV phylogenetics, epidemiology and resistance marker analysis. Andrey has been awarded a four-year UNSW-CSIRO Industry PhD (iPhD) scholarship in partnership with SpeeDx, an Australian company specialising in molecular diagnostics. The industry focussed iPhD scheme is an applied research training program designed to develop scholars with the skills to work at the interface between research and industry. Andrey will be co-supervised by Tanya Applegate (Kirby Institute), Denis Bauer (CSIRO) and Elisa Mokany (SpeeDx) and will work closely with partners of the ARC Hub to combat antimicrobial resistance to develop machine learning tools to identify genetic markers that will inform the development of new diagnostic tools for antimicrobial resistance of Neisseria Gonorrhoeae.
Mr Andrey Verich
2013-2018 at UNSW Bachelor of Science (Advanced) (1st Class Honours)
Publications
Journal articles
Preprints
Research activities
Journal articles
Bartlett SR; Verich A; Carson J; Hosseini-Hooshyar S; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle JS; Shaw D; Hellard M; Martinez M; Marks P; Dore GJ; Matthews GV; Applegate T; Martinello M, 2022, 'Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct-acting antiviral era: A molecular epidemiology study among participants in the CEASE cohort', Health Science Reports, vol. 5, http://dx.doi.org/10.1002/hsr2.719
Kim KW; Deveson IW; Pang CNI; Yeang M; Naing Z; Adikari T; Hammond JM; Stevanovski I; Beukers AG; Verich A; Yin S; McFarlane D; Wilkins MR; Stelzer-Braid S; Bull RA; Craig ME; van Hal SJ; Rawlinson WD, 2021, 'Respiratory viral co-infections among SARS-CoV-2 cases confirmed by virome capture sequencing', Scientific Reports, vol. 11, pp. 3934, http://dx.doi.org/10.1038/s41598-021-83642-x
Bull RA; Adikari TN; Ferguson JM; Hammond JM; Stevanovski I; Beukers AG; Naing Z; Yeang M; Verich A; Gamaarachchi H; Kim KW; Luciani F; Stelzer-Braid S; Eden JS; Rawlinson WD; van Hal SJ; Deveson IW, 2020, 'Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis', Nature Communications, vol. 11, pp. 6272, http://dx.doi.org/10.1038/s41467-020-20075-6
Kim KW; Deveson IW; Pang CNI; Yeang M; Naing Z; Adikari T; Hammond JM; Stevanovski I; Beukers AG; Verich A; Yin S; McFarlane D; Wilkins MR; Stelzer-Braid S; Bull RA; Craig ME; Hal SJV; Rawlinson WD, 2020, 'Respiratory viral co-infections among SARS-CoV-2 cases confirmed by virome capture sequencing', , http://dx.doi.org/10.21203/rs.3.rs-105996/v1
Grebely J; Catlett B; Jayasinghe I; Valerio H; Hajarizadeh B; Verich A; Cunningham P; Martinello M; Tillakeratne S; Silk D; Dore GJ; Applegate TL, 2020, 'Time to Detection of Hepatitis C Virus Infection with the Xpert HCV Viral Load Fingerstick Point-of-Care Assay: Facilitating a More Rapid Time to Diagnosis', Journal of Infectious Diseases, vol. 221, pp. 2043 - 2049, http://dx.doi.org/10.1093/infdis/jiaa037
Preprints
Bull RA; Adikari T; Ferguson JM; Hammond JM; Stevanovski I; Beukers AG; Naing Z; Yeang M; Verich A; Gamaarachchi H; Kim KW; Luciani F; Stelzer-Braid S; Eden J-S; Rawlinson WD; van Hal SJ; Deveson IW, 2020, Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis, http://dx.doi.org/10.1101/2020.08.04.236893